Discriminant analysis to study trace elements in biomonitoring: An application on neurodegenerative diseases

Annali dell'Istituto Superiore di Sanita

Volumn 41, Issue 2, 2005, Pages 223-228

  Pino, Anna ^a   Brescianini, Sonia ^a   D'Ippolito, Cristina ^a   Fagnani, Corrado ^a   Alimonti, Alessandro ^a   Stazi, Maria Antonietta ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Alzheimer's disease; Discriminant analysis; Multiple sclerosis; Neurodegenerative diseases; Parkinson's disease; Trace elements

Indexed keywords

CALCIUM; COBALT; COPPER; IRON; LEAD; NICKEL; TRACE ELEMENT; ZIRCONIUM;

ADULT; ALZHEIMER DISEASE; ARTICLE; BIOLOGICAL MONITORING; BLOOD LEVEL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISCRIMINANT ANALYSIS; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; QUANTITATIVE ANALYSIS;

ADULT; AGED; ALZHEIMER DISEASE; DISCRIMINANT ANALYSIS; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; TRACE ELEMENTS;

EID: 31644446276     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Crapper DR, Krishnan SS, Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain 1976;99:67-80.
2. Garruto RM, Shankar C, Yanagihara R, Salazar AM, Gajdusek DC. Low-calcium, high-aluminum motor neuron pathology in Cynomolgus monekeys. Acta Neuropathol 1989;78:210-9.
3. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease: An X-ray microanalysis. J Neurochem 1991;56:446-51.
4. Yasui M, Kihira T, Ota K. Calcium, Magnesium and aluminum concentrations in Parkinson's disease. Neurotoxicology 1992;13:593-600.
5. Yates CM, Simpson J, Russell D, Gordon A. Cholinergic enzymes in neurofibrillary degeneration produced by aluminum. Brain Res 1980;197:267-74.
6. Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, Rottkamp CA, Smith MA. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 2002;16(5):339-52.
7. Mattson MP, Chan SL. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J Mol Neurosci 2001;17:376-89.
8. Pereira C, Ferreiro E, Cardoso SM, de Oliveira CR. Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease. J Mol Neurosci 2004;23(1-2):97-104.
9. Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? J Clin Invest 2003;111(2):163-9.
10. Wyrzykowska B, Szymczyk K, Ichichashi H, Falandysz J, Skwarzec B, Yamasaki S. Application of ICP sector field MS and principal component analysis for studying interdipendences among 23 trace elements in polish beers. J Agric Food Chem 2001;49:3425-31.
11. Devillers J, Doré JC, Marenco M, Poirier-Duchene F, Galand N, Viel C. Chemometrical analysis of 18 metallic and non-metallic elements found in honeys sold in France. J Agric Food Chem 2002;50:5998-6007.
12. Orlandi M, Pelfini M, Pavan M, Santilli M, Colombini MP. Heavy metals variations in some conifers in Valle d'Aosta (western Italian Alps) from 1930 to 2000. Microchemical Journal 2002;73:237-44.
13. 99mTc HmPAO SPECT data. J Neurol Neurosurg Psychiatry 2000;69:661-3.
14. Hampel H, Teipel SJ, Padberg F, Haslinger A, Riemenschneider M, Schwarz , Kötler HU, Scheloske M, Buch K, Stübner S, Dukoff R, Lasser R, Müller N, Sunderland T, Rapoport SI , Möller H-J. Discriminant power of combined cerebrospinal fluid tau-protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. Brain Research 1999;823:104-12.
15. Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei G, Alimonti A. Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann 1st Super Sanità 2005;41(2):197-203.
16. Forte G, Visconti A, Santucci S, Ghazaryan A, Figà-Talamanca L, Cannoni S, Bocca B, Pino A, Violante N, Alimonti A, Salvetti M, Ristori G. Quantification of chemical elements in blood of patients affected by multiple sclerosis. Ann 1st Super Sanità 2005;41 (2):213-6.
17. Forte G, Alimonti A, Pino A, Stanzione P, Brescianini S, Brusa L, Sancesario G, Violante N, Bocca B. Metals and oxidative stress in patients with Parkinson's disease. Ann 1st Super Sanità 2005;41(2):189-95.
18. Bocca B, Forte G, Petrucci F, Senofonte O, Violante N, Alimonti A. Development of methods for the quantification of essential and toxic elements in human biomonitoring. Ann 1st Super Sanità 2005;41(2):165-70.
19. Morrison DF. Multivariate statistical methods. Tokyo: Mc Graw-Hill; 1976.
20. Stojanovic D, Nikic D, Lazarevic K. The level of nickel in smoker's blood and urine. Central European Journal of Public Health 2004;12(4):187-9.
21. Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 2001;276(47): 44284-96.
22. Markovac J, Goldstein GW. Picomolar concentration of lead stimulate brain protein kinase C. Nature 1988;334:71-3.
23. Persson E, Henriksson J, Tjälve H. Uptake of cobalt from nasal mucosa into the brain via olfactory pathways in rats. Toxicol Lett 2003;145:19-27.
24. Ripova D, Platilova V, Strunecka A, Jirak R, Hoschl C. Alterations in calcium homeostasis as biological marker for mild Alzheimer's disease? Physiol Res 2004;53(4):449-52.
25. Fujita T. Alzheimer disease and calcium. Clin Ca 2004;14(1): 103-5.
26. Kienzl E, Jellinger K, Stachelberger H, Linert W. Iron as catalist for oxidative stress in the pathogenesis of parkinson's disease? Life Sci 1999;65:1973-6.
27. Cuajungco MP, Friederickson CJ, Bush AI. Amyloid-beta metal interaction and metal chelation. Sub-cell Biochem 2005;38:235-54.
28. Rogers JT, Lahiri DK. Metal and inflammatory targets for Alzheimer's disease. Curr Drug Targets 2004;5(6):535-51.
29. Linder MC and Hazegh-Azam M. Copper biochemistry and molecular biology. Am J Clin Nutr 1996;63(Suppl.):797S-811S.
30. Strausak D, Mercer IF, Dieter HH, Stremmel W, Multhaup G. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull 2001;55:175-85.
31. Prince M. Is chronic low-level lead exposure in early life an etiologic factor in Alzheimer's disease? Epidemiology 1998;9(6):618-21.